Error: Could not add to watchlist. X

Karo Bio AB

+ Watchlist
KA6:GR
Frankfurt
0.11
EUR
0.00
0.92%
As of 03:06:31 ET on 07/07/2015.
Open
0.13
Day Range
0.11 - 0.13
Volume
0
Previous Close
0.11
52Wk Range
0.02 - 0.19
1 Yr Return
50.36%
Current P/E Ratio (TTM)
-
Earnings per Share (SEK) (TTM)
-
Market Cap (m EUR)
136.735
Shares Outstanding (m)
689.744
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Karo Bio AB operates a drug research and development company. The Company develops precision drugs to treat major diseases in the field of nuclear receptors. Karo Bio works within many therapeutic areas including men and women's health, cardiovascular diseases, metabolic disorders and dermatology.
ADDRESS
Halsovagen 7
Huddinge, 141 57
Sweden
PHONE
46-8-608-60-00
  • Maria Sjoeberg
    Chief Executive Officer
  • Henrik Palm
    Vice CEO/CFO
  • Mark Farmery
    Head:Business Development
Show More